Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 6 , Pages 808-814 , December 2010

Effect of cholesterol and amyloid-β peptide on structure and function of mixed-lipid films and pulmonary surfactant BLES: an atomic force microscopy study

  • Francis Hane, MSc, BSc

      Affiliations

    • Department of Biology, University of Waterloo, Waterloo, Canada
    • ,
  • Elizabeth Drolle, BSc

      Affiliations

    • Department of Biology, University of Waterloo, Waterloo, Canada
    • ,
  • Zoya Leonenko, BSc, PhD

      Affiliations

    • Department of Biology, University of Waterloo, Waterloo, Canada
    • Department of Physics and Astronomy, University of Waterloo, Waterloo, Canada
    • Corresponding Author InformationCorresponding author: University of Waterloo, 200 University Avenue, Waterloo, Ontario, Canada N2L 3G1.

Received 3 February 2010 ,Accepted 3 May 2010.

References 

  1. Scarpelli EM, Clutario BC, Taylor FA. Preliminary identification of the lung surfactant system. J Appl Physiol. 1967;23:880–886
  2. Holm B, Enhorning G, Notter RH. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem Phys Lipids. 1988;49:49–55
  3. Floros J, Phelps DS, Pison U, Spragg R. Pulmonary surfactant—update on function, molecular biology and clinical implications. Respir Med Rev. 2005;1:77–84
  4. Clements J. Surface tension of lung extracts. Proc Soc Exp Biol Med. 1957;95:170–172
  5. Johansson J, Curstedt T. Molecular structures and interactions of pulmonary surfactant components. Eur J Biochem. 1997;244:675–693
  6. Crewels LA, van Golde LM, Haagsman HP. The pulmonary surfactant system: biochemical and clinical aspects. Lung. 1997;175:1–39
  7. Poulain FR, Clements JA. Pulmonary surfactant therapy. West J Med. 1995;162:43–50
  8. Leonenko Z, Gill S, Baoukina S, Monticelli L, Doehner J, Gunasekara L, et al. An elevated level of cholesterol impairs self assembly of pulmonary surfactant into a functional film. Biophys J. 2007;93:674–683
  9. Amrein M, von Nahmen A, Sieber M. A scanning force-and fluorescence light microscopy study of the structure and function of a model pulmonary surfactant. Eur Biophys J. 1997;26:349–357
  10. Gunasakara L, Schurch S, Schoel M, Kaushik N, Leonenko Z, Haufs M, et al. Pulmonary surfactant function is abolished by an elevated proportion of cholesterol. Biochim Biophys Acta. 2005;1737:27–35
  11. Johannsson J. Structure and properties of surfactant protein C. Biochim Biophys Acta. 1998;1408:161–172
  12. Li D. The model of the action mechanism of Sp-C in the lung surfactant monolayers. Coll Surf. 2007;57:27–28
  13. Nakorn P, Meyer MC, Flach CR, Mendelsohn R, Galla HJ. Surfactant protein C and lung function: new insights into the role of alpha-helical length and palmitoylation. Eur Biophys. J. 2007;36:477–489
  14. Johannsson J. Amyloid fibrils. FEBS J. 2005;272:5941
  15. Gustaffson M. Amyloid fibril formation by pulmonary surfactant protein C. FEBS Lett. 1999;464:138–142
  16. Dobson CW. The structural basis of protein folding and its links with human disease. Philos Trans R Soc Lond B Biol Sci. 2001;356:133–145
  17. Nelson R, Eisenberg D. Recent atomic models of amyloid fibril structure. Curr Opin Struct Bio. 2006;16:260–265
  18. Robertson E, Mucke L. 100 years and counting: prospects for defeating Alzheimer's disease. Science. 2006;314:781–785
  19. Kallberg Y, Gustafsson M, Persson B, Thyberg J, Johansson J. Prediction of amyloid fibril-forming proteins. J. Biol Chem. 2000;276:12945–12950
  20. Rauk A. The chemistry of Alzheimer's disease. Chem Soc Rev. 2009;38:2698–2715
  21. Engle WA. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics. 2008;121:419–432
  22. Tanaka Y, Takei T, Aiba T, Masuda K, Kiuchi A, Fujiwara T. Development of synthetic lung surfactants. J Lipid Res. 1986;27:475–485
  23. Cai P, Flach C, Mendelsohn R. An infrared reflection-absorption spectroscopy study of the secondary structure in (KL4)4K, a therapeutic agent for respiratory distress syndrome, in aqueous monolayers with phospholipids. Biochemistry. 2003;42:9446–9452
  24. Nakahara H, Lee S, Sugihara G, Chang CH, Shibata O. Langmuir monolayer of artificial pulmonary surfactant mixtures with an amphiphilic peptide at the air/water interface: comparison of new preparations with surfacten (Surfactant TA). Langmuir. 2008;24:3370–3379
  25. Gustafsson M, Palmblad M, Curstedt T, Johansson J, Schürch S. Palmitoylation of a pulmonary surfactant protein C analogue affects the surface associated lipid reservoir and film stability. Biochim Biophys Acta. 2000;1466:169–178
  26. Krol S, Ross M, Sieber M, Kunneke S, Galla HJ, Janshoff A. Formation of three-dimensional protein-lipid aggregates in monolayer films induced by surfactant protein B. Biophys J. 2000;79:904–918
  27. Grigoriev D, Kragel J, Akentiev A, Noskov B, Miller R, Pison U. Relation between rheological properties and structural changes in monolayers of model lung surfactant under compression. Biophys Chem. 2003;104:633–642
  28. Fezoui Y, Hartley D, Harper J, Khurana R, Walsh D, Condron M, et al. An improved method of preparing the amyloid-β protein for fibrillogenesis and neurotoxicity experiments. Amyloid:. Int. J. Exp. Clin. Invest. 2000;7:166–178
  29. Choucair A, Chakrapani M, Chakravarthy B, Katsaras J, Johnston LJ. Preferential accumulation of Abeta(1-42) on gel phase domains of lipid bilayers: an AFM and fluorescence study. Biochim Biophys Acta. 2007;1768:146–154
  30. Pike LJ. Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. J Lipid Res. 2006;47:1597–1598
  31. Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science. 2010;327:46–50
  32. Pike LJ. The challenge of lipid rafts. J Lipid Res. 2009;50(Suppl):S323–S328
  33. Kim YH, Tero R, Takizawa U, Urisu T. Characterization of dipalmitoylphosphatidylcholine/cholesterol Langmuir-Blodgett monolayers investigated by atomic force microscopy and Fourier transform infrared spectroscopy. Jpn J Appl Phys I Reg Papers. 2004;43:3860–3864
  34. Yuan C, Johnston LJ. Phase evolution in cholesterol/DPPC monolayers: atomic force microscopy and near field scanning optical microscopy studies. J Microsc. 2002;205:136–146
  35. Murtola T, Karttunen M, Vattulainen I. Systematic coarse graining from structure using internal states: application to phospholipid/cholesterol bilayer. J Chem Phys. 2009;055101:131
  36. Finot E, Leonenko Y, Moores B, Eng LM, Amrein M, Leonenko Z. Effect of cholesterol on electrostatics in lipid-protein films of a lung surfactant. Langmuir. 2010;26:1929–1935
  37. Hane F, Moores B, Amrein M, Leonenko Z. Effect of SP-C on surface potential distribution in pulmonary surfactant: atomic force microscopy and Kelvin-probe force microscopy study. Ultramicroscopy. 2009;109:968–973
  38. Ji SR, Wu Y, Sui SF. Study of β-amyloid peptide (Aβ40) insertion into phospholipid membranes using monolayer technique. Biochemistry (Mosc.). 2002;67:1283–1288
  39. Kucerka N, Pencer J, Nieh MP, Katsaras J. Influence of cholesterol on the bilayer properties of monounsaturated phosphatidylcholine unilamellar vesicles. Eur Phys J E. 2007;23:247–254
  40. Leonenko Z, Finot E, Vassiliev V, Amrein M. The structure and physical properties of BLES surfactant films addressed by atomic force microscopy and force measurements. Ultramicroscopy. 2006;106:687–694

 Funding sources: Natural Sciences and Engineering Council of Canada (NSERC), Canada Foundation for Innovation (CFI), Ontario Ministry of Research and Innovation, Ontario Research Fund (ORF) and NSERC Undergraduate Student Research Award to ED.

PII: S1549-9634(10)00155-3

doi: 10.1016/j.nano.2010.05.001

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 6 , Pages 808-814 , December 2010

Article Tools

* Image Usage & Resolution